Cancer Research Institute
Meets Standards

Standards For Charity Accountability
Governance
-
Board Oversight
-
Board Size
-
Board Meetings
-
Board Compensation
-
Conflict of Interest
Measuring Effectiveness
-
Effectiveness Policy
-
Effectiveness Report
Finances
-
Program Expenses
-
Fundraising Expenses
-
Accumulating Funds
-
Audit Report
-
Detailed Expense Breakdown
-
Accurate Expense Reporting
-
Budget Plan
Fundraising & Info
-
Truthful Materials
-
Annual Report
-
Website Disclosures
-
Donor Privacy
-
Cause Marketing Disclosures
-
Complaints
Cancer Research Institute meets the 20 Standards for Charity Accountability.
Stated Purpose:
"to save more lives by fueling the discovery and development of powerful immunotherapies for all cancers."
Year, State Incorporated:
1953, NY
Cancer Research Institute (CRI) funds research at academic centers around the world through fellowships, grants, and clinical trials focused on harnessing the immune system's power to conquer all forms of cancer. CRI also provides information to the public about cancer immunotherapy and connects patients to immunotherapy clinical trials. During the year ended June 30, 2022, the organization reports that it awarded 80 research grants totaling $22.1 million.
For the year ended June 30, 2022, Cancer Research Institute's program expenses were:
Research | $22,147,985 |
Science, medical and research information, and communications | $4,083,694 |
Total Program Expenses | $26,231,589 |
Chief Executive
Jill O'Donnell-Tormey, Chief Executive Officer and Director of Scientific Affairs
Compensation*
$564,003
Chair of the Board
Paul C. Shiverick
Chair's Profession / Business Affiliation
Retired, Co-founder, Seminole Capital Partners
Board Size
34
Paid Staff Size
26
*2021 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Note: Andrew K. Tsai serves as Co-Chair of the board of directors.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Direct mail appeals, Radio, Special events, Print advertisements
Cancer Research Institute incurred joint costs of $60,735 for informational materials and activities that included fundraising materials. Of those costs $45,551 was allocated to fundraising expenses and $15,184 was allocated to program expenses.
Fundraising costs were 12% of related contributions. (Related contributions, which totaled $29,277,358, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Cancer Research Institute's audited financial statements for the year ended June 30, 2022.
Source of Funds
Net investment loss in excess of investment activity | $-8,165,591 |
Rental income, net | $21,476 |
Miscellaneous | $72,651 |
Donated services | $543,693 |
Combined federal campaigns | $559,676 |
Special events | $675,506 |
Gain on loan forgiveness | $710,150 |
Investment income allocation | $3,121,803 |
Cancellation of grants | $4,531,239 |
Bequests and memorials | $5,336,419 |
Contributions | $9,757,596 |
Designated contributions | $11,694,318 |
Total Income | $28,858,936 |
Programs: 84% Fundraising: 11% Administrative: 5%
Total Income | $28,858,936 |
Total expenses: | $31,389,626 |
Program expenses | $26,231,589 |
Fundraising expenses | $3,522,149 |
Administrative expenses | $1,635,888 |
Other expenses | $0 |
Income in Excess of Expenses | $-2,530,690 |
Beginning Net Assets | $74,455,635 |
Other Changes In Net Assets | $4,946,309 |
Ending Net Assets | $66,704,762 |
Total Liabilities | $63,733,550 |
Total Assets | $130,438,312 |
Note: In the above financial section, "other changes in net assets" represent allowance for uncollectible accounts ($5,083,246) and change in value of perpetual trust (-$136,937).
An organization may change its practices at any time without notice. A copy of this report has been shared with the organization prior to publication. It is not intended to recommend or deprecate, and is furnished solely to assist you in exercising your own judgment. If the report is about a charity and states the charity meets or does not meet the Standards for Charity Accountability, it reflects the results of an evaluation of information and materials provided voluntarily by the charity. The name Better Business Bureau is a registered service mark of the International Association of Better Business Bureaus.
This report is not to be used for fundraising or promotional purposes.